Abstract
Motor neuron disease (MND) includes a group of diseases that affect motor neurons of the spinal cord. The spinal cord being the sole communication link between the brain and parts below the neck, any injury due to any etiology from autoimmune to excitotoxic affecting the spinal cord invariably results in dreaded sensory and motor neuronal and its loss of control. Mankind’s knowledge in the field and recognition of spinal cord injury and its consequences date back to 2500 B.C. as is evident from vivid descriptions given in Greek Papyrus archival material. Despite such early recognition, pathophysiology and prospective therapies affecting the spinal cord or its different constituents and their coordination were not identified until the early part of previous century.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Motor Neuron Diseases Fact Sheet, National Institute of Neurological Disorders and Stroke, NIH, www.ninds.nih.gov. http://www.ninds.nih.gov/disorders/motor_neuron_diseases/motor_neuron_diseases.htm. Accessed on 5th Oct 2012.
Johnson FO, Yuan Y, Hajela RK, Chitrakar A, Parsell DM, Atchison WD. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity. J Pharmacol Exp Ther. 2011;338(2):518–27. doi:10.1124/jpet.110.174466.
Miller RG, Mitchell J, Lyon M, Moore D. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (1):CD001447. doi:10.1002/14651858.CD001447.pub2.
Samanta BK, Chandra NC, Ghosh S, Mukherjee KL. Aldose metabolism in developing human fetal brain and liver. Experientia. 1984;40(12):1420–2.
Grégoire C, Yury G, van den Rubia B, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci. 2009;12:1333–42.
Bhattacharya N, Mukherjee K, Chhetri MK, Banerjee T, Mani U, Bhattacharya S. A study report of 174 units of placental umbilical whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. Clin Exp Obstet Gynecol. 2001;28(1):47–52.
Bhattacharya N, Mukherjee KL, Chhetri MK, et al. An unique experience with human pre-immune (12 weeks) and hypo-immune (16 weeks) fetal thymus transplant in a vascular subcutaneous axillary fold in patients with advanced cancer – a report of two cases. Eur J Gynaecol Oncol. 2001;22(4):273–7.
Bhattacharya N. Fetal tissue/organ transplant in HLA randomized adults’ vascular subcutaneous axillary fold – a preliminary report of 14 patients. Clin Exp Obstet Gynecol. 2001;28(4):233–9.
Bhattacharya N. Fetal cell/tissue therapy in adult disease – a new horizon in regenerative medicine. Clin Exp Obstet Gynecol. 2004;31:167–73.
Thomas M, Yang L, Hornsby PJ. Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nat Biotechnol. 2000;18(1):39–42.
Bhattacharya N, Chaudhuri N, Banerjee S, Mukherjee KL. Intraamniotic tetanus toxoid as a safe abortifacient. Indian J Med Res. 1979;70:435–9.
Bhattacharya N. Letter to the editor. Clin Exp Obstet Gynecol. 1996;23:272–5.
Bhattacharya N. Intraamniotic instillation of tetanus toxoid: a safe, cheap, effective abortifaecient in the light of our experiences with different intraamniotic instillation of antigens for alteration of pregnancy immunotolerance – A study from 1978 to 1996. In: Tambiraja RL, Ho NK, editors. Relevance and excellence in perinatal care, Proceedings of the 9th congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov 1996. Bolonga: Monduzzi Editore; 1996. p. 193–200
Bhattacharya N. Dissolution of the fetus: a new experience with intraamniotic BCG instillation. In: Tambiraja RL, Ho NK, editors. Relevance and excellence in perinatal care, Proceedings of the 9th Congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov 1996. Bolonga: Monduzzi Editore; 1996. p. 201–6.
Bhattacharya N. Study of the aborted fetus after intraamniotic instillation of tetanus toxoid. In: Tambiraja RL, Ho NK, editors. Relevance and excellence in perinatal care, Proceedings of the 9th congress of the Federation of the Asia and Oceania Perinatal Societies, Singapore, Nov 1996. Bolonga: Monduzzi Editore; 1996. p. 187–92.
Bhattacharya N. A study on the intraamniotic instillation of tetanus toxoid on a growing human fetus. D.Sc. dissertation, Faculty of Medicine, Calcutta University, Kolkata; 2001.
Deacon T, Schumacher J, Dinsmore J, Thomas C, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nat Med. 1997;3(3):350–3.
Freed CR, Green PE, Breeze RE, Tsai WY. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med. 2001;344:710–9.
Wenning GK, Ordin P, Morrish P, Rehncrona S. Short and long term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease. Ann Neurol. 1997;42(1):95–107.
Hoffer B, van Horne C. Survival of dopaminergic neurons in fetal tissue graft. N Engl J Med. 1995;332:1163–4.
Yrjö TK, Emilia K, Vasily S, Wagner HD, Jaakko L, Veli-Matti T, Zygmunt M. Extracellular matrix and tissue regeneration. In: Gustav S, editor. Regenerative medicine. Dordrecht: Springer; 2011. p. 21–80. doi:10.1007/978-90-481-9075-1_2. Part 1.
Bhattacharya N, Chhetri MK, Mukherjee KL, Ghosh AB, Samanta BK, Mitra R, Bhattacharya M, Bhattacharya S, Bandopadhyaya T. “Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson’s disease”. Clin Exp Obstet Gynecol. 2002;29(4):259-66..
Acknowledgment
The Department of Science and Technology, Government of West Bengal, supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006. The work started at Bijoygarh Government Hospital (1999–2006) and was followed up at Vidyasagore Government Hospital subsequently. The author gratefully acknowledges the support of the patients who volunteered for this research work. The guidance of Prof. K. L. Mukherjee of Biochemistry; Prof. M. K. Chhetri, former Director of Health Services; and Dr. Abhijeet Chaudhuri, Lead Neurologist, Essex Centre for Neurological Sciences, Romford, UK, are also acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Bhattacharya, N. (2013). Treatment by Human Fetal Neuronal Tissue Transplant at a Heterotopic Site in the Axilla in Case of Motor Neuron Disease: A Report of Two Cases. In: Bhattacharya, N., Stubblefield, P. (eds) Human Fetal Tissue Transplantation. Springer, London. https://doi.org/10.1007/978-1-4471-4171-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4171-6_25
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4170-9
Online ISBN: 978-1-4471-4171-6
eBook Packages: MedicineMedicine (R0)